TY  - GEN
AU  - Gerber,David E
AU  - Urbanic,James J
AU  - Langer,Corey
AU  - Hu,Chen
AU  - Chang,I-Fen
AU  - Lu,Bo
AU  - Movsas,Benjamin
AU  - Jeraj,Robert
AU  - Curran,Walter J
AU  - Bradley,Jeffrey D
TI  - Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505)
SN  - 1938-0690
PY  - 2018///0309
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carcinoma, Non-Small-Cell Lung
KW  - mortality
KW  - Chemoradiotherapy
KW  - Cisplatin
KW  - Combined Modality Therapy
KW  - Etoposide
KW  - Humans
KW  - Immunotherapy
KW  - methods
KW  - Lung Neoplasms
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Nivolumab
KW  - Placebo Effect
KW  - Proportional Hazards Models
KW  - Research Design
KW  - Survival Analysis
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.cllc.2016.10.009
ER  -